Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Stage III Adult Soft Tissue Sarcoma: early-phase trial registry

A small indexed set (6 trials) with no open enrollment listed right now.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

6 US clinical trials · none currently recruiting · #2,866 of 28,707 conditions by registered trial count

Stage III Adult Soft Tissue Sarcoma: 6 US clinical trials tracked, none currently recruiting.

Stage III Adult Soft Tissue Sarcoma is the subject of 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 3 of these trials.

Enrollment posture brief

Registry condition stage-iii-adult-soft-tissue-sarcoma

OPEN 0 | RECR 0% | LATE 0 | EARLY 6 | RANK #2866 | SPON 3

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Stage III Adult Soft Tis (th…0%
Open-enrollment share among volume-matched conditions near Stage III Adult Soft Tissue Sarcoma

Stage III Adult Soft Tissue Sarcoma has no open enrollment in this registry pull (6 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stage III Adult Soft Tissue Sarcoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stage III Adult Soft Tissue Sarcoma is recruiting below its size-band peers.

    0 of 6 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Stage III Adult Soft Tissue Sarcoma research.

    National Cancer Institute (NCI) accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Stage III Adult Soft Tissue Sarcoma trials plan to enrol fewer than 100 people.

    Median target enrolment is 55 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.

  4. Stage III Adult Soft Tissue Sarcoma research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 25

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 5

Top Sponsors

National Cancer Institute (NCI) 3 trials
University of Vermont 1 trials
Northwestern University 1 trials
Wake Forest University Health Sciences 1 trials

Named interventions

Most-linked intervention names on Stage III Adult Soft Tissue Sarcoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

laboratory biomarker analysis Other
3 trials
tivozanib Drug
1 trials
temsirolimus Drug
1 trials
sorafenib tosylate Drug
1 trials
therapeutic angiotensin-(1-7) Drug
1 trials
bortezomib Drug
1 trials
Pazopanib Drug
1 trials
vorinostat Drug
1 trials

US sites by state

Facility locations filed on Stage III Adult Soft Tissue Sarcoma trials. A trial with sites in several states counts in each.

Minnesota 3 trials
Wisconsin 2 trials
Missouri 2 trials
Vermont 1 trials
New York 1 trials
North Carolina 1 trials
Maryland 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Stage III Adult Soft Tissue Sarcoma page

6 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Stage III Adult Soft Tissue Sarcoma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • National Cancer Institute (NCI) sponsors the most Stage III Adult Soft Tissue Sarcoma trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stage III Adult Soft Tissue Sarcoma condition card totals 6 registered trials; most-linked intervention laboratory biomarker analysis; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.